Health

Results: 1657-1668 of 6447

Vertex Announces UK MHRA Approval of ALYFTREK® (Deutivacaftor/Tezacaftor/Vanzacaftor), a Once-Daily Next-in-Class CFTR Modulator for the Treatment of Cystic Fibrosis

Innovaderm Research Rebrands as Indero, a Dual-Focus CRO

Reflow Medical Expands Global Reach with New European Subsidiary

PR Newswire associated0

Orphalan becomes the first European company to enter in China's Wilson Disease market

Life Thrives in the Deepest Ocean: New Discoveries from the Mariana Trench

PR Newswire associated0

HAVAS HEALTH NETWORK LAUNCHES ITS GLP-1 CONSULTANCY IN PARIS WITH "SHAPE SHIFTING" EVENT ON HEALTH AND WELLNESS

Sangamo Therapeutics Announces Fourth Quarter and Full Year 2024 Earnings Call and Participation in Upcoming Investor Conference

PR Newswire associated0

Elsevier Health launches HESI Clinical Practice Readiness Assessment (CPRA): the first assessment of its kind to assess nursing students' practice readiness

Evolution Optiks Expands IP Portfolio with Two Key U.S. Patents for Light Field Powered Tele-Refractor

Novotech Releases Hepatitis B Global Clinical Trial Landscape Report 2025

Almirall HQ in Barcelona (Photo: Business Wire)

Almirall Announces CFO Transition Plan and Appoints Jon U. Garay Alonso as CFO to Succeed Mike McClellan in August 2025

Galderma Delivers 2024 Record Net Sales of 4.410 Billion USD, up 9.3% Year-on-Year at Constant Currency1, and Record Core EBITDA of 1.031 Billion USD, While Preparing to Accelerate Its Growth Trajectory Into 2025 and Beyond